NO940810D0 - Behandling av virusinfeksjoner - Google Patents

Behandling av virusinfeksjoner

Info

Publication number
NO940810D0
NO940810D0 NO940810A NO940810A NO940810D0 NO 940810 D0 NO940810 D0 NO 940810D0 NO 940810 A NO940810 A NO 940810A NO 940810 A NO940810 A NO 940810A NO 940810 D0 NO940810 D0 NO 940810D0
Authority
NO
Norway
Prior art keywords
treatment
viral infections
infections
viral
Prior art date
Application number
NO940810A
Other languages
English (en)
Other versions
NO940810L (no
Inventor
David Frederick Horrobin
Michael David Winther
Original Assignee
Scotia Holdings Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Scotia Holdings Plc filed Critical Scotia Holdings Plc
Publication of NO940810D0 publication Critical patent/NO940810D0/no
Publication of NO940810L publication Critical patent/NO940810L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C11/00—Aliphatic unsaturated hydrocarbons
    • C07C11/21—Alkatrienes; Alkatetraenes; Other alkapolyenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO940810A 1993-03-09 1994-03-08 Behandling av virusinfeksjoner NO940810L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939304746A GB9304746D0 (en) 1993-03-09 1993-03-09 Treatment of viral infections

Publications (2)

Publication Number Publication Date
NO940810D0 true NO940810D0 (no) 1994-03-08
NO940810L NO940810L (no) 1994-09-12

Family

ID=10731687

Family Applications (1)

Application Number Title Priority Date Filing Date
NO940810A NO940810L (no) 1993-03-09 1994-03-08 Behandling av virusinfeksjoner

Country Status (9)

Country Link
EP (1) EP0615752A1 (no)
JP (1) JPH072663A (no)
KR (1) KR940021056A (no)
CN (1) CN1100931A (no)
AU (1) AU5758594A (no)
CA (1) CA2117214A1 (no)
GB (1) GB9304746D0 (no)
NO (1) NO940810L (no)
NZ (1) NZ260052A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997025415A1 (de) * 1996-01-05 1997-07-17 Cesa, Clean Energy S.A. Verfahren zur deaktivierung der hiv und anderer viren
US6576636B2 (en) 1996-05-22 2003-06-10 Protarga, Inc. Method of treating a liver disorder with fatty acid-antiviral agent conjugates
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
EP1042341A1 (en) * 1997-11-25 2000-10-11 Protarga Inc. Nucleoside analog compositions and uses thereof
DE19836339B4 (de) 1998-08-11 2011-12-22 N.V. Nutricia Kohlenhydratmischung
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
AUPR030800A0 (en) * 2000-09-22 2000-10-12 Pharmalink International Limited Immunomodulatory preparation
US8552054B2 (en) 2001-03-23 2013-10-08 Luitpold Pharmaceuticals, Inc. Fatty amine drug conjugates
JP4634694B2 (ja) 2001-03-23 2011-02-16 ルイトポルド・ファーマシューティカルズ・インコーポレーテッド 脂肪アルコール薬物複合体
EP1597978A1 (en) 2004-05-17 2005-11-23 Nutricia N.V. Synergism of GOS and polyfructose
US8252769B2 (en) 2004-06-22 2012-08-28 N. V. Nutricia Intestinal barrier integrity
PT1758469E (pt) * 2004-06-22 2010-02-03 Nutricia Nv Melhoria da integridade da barreira nos doentes com vih com o uso de ácidos gordos
CN110339187B (zh) * 2019-07-30 2021-12-14 中国医学科学院病原生物学研究所 缓解寨卡病毒感染相关的新生儿小头症的药物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8319073D0 (en) * 1983-07-14 1983-08-17 Efamol Ltd Fatty acid compositions
GB8320203D0 (en) * 1983-07-27 1983-09-01 Horrobin D F Anti-viral compositions
DE3863678D1 (de) * 1987-04-27 1991-08-22 Efamol Holdings Lithiumsalze enthaltende pharmazeutische zubereitungen.
US4997851A (en) * 1987-12-31 1991-03-05 Isaacs Charles E Antiviral and antibacterial activity of fatty acids and monoglycerides
HU209973B (en) * 1988-03-09 1995-01-30 Biorex Kutato Fejlesztoe Kft Process for production of antiviral and immunstimular pharmaceutical composition
EP0400547A1 (en) * 1989-06-02 1990-12-05 Abbott Laboratories Parenteral nutrition product
GB8918294D0 (en) * 1989-08-10 1989-09-20 Efamol Holdings Pharmaceutical compositions
GB9111900D0 (en) * 1991-06-03 1991-07-24 Efamol Holdings Fatty acid compositions
US5604258A (en) * 1991-06-24 1997-02-18 Women's And Children's Hospital Adelaide Methods for treating malaria and other diseases
GB9116054D0 (en) * 1991-07-24 1991-09-11 Efamol Holdings Preparation of fatty acid medicaments
EP0585057A1 (en) * 1992-08-25 1994-03-02 Scotia Holdings Plc Lithium salts of fatty acids for the treatment of viral infections and cancer

Also Published As

Publication number Publication date
CN1100931A (zh) 1995-04-05
GB9304746D0 (en) 1993-04-28
KR940021056A (ko) 1994-10-17
JPH072663A (ja) 1995-01-06
AU5758594A (en) 1994-09-15
EP0615752A1 (en) 1994-09-21
NZ260052A (en) 1997-06-24
NO940810L (no) 1994-09-12
CA2117214A1 (en) 1994-09-10

Similar Documents

Publication Publication Date Title
NO991700D0 (no) Benzimidazol-2-karbamater for behandling av virusinfeksjoner og cancer
NO934304L (no) Fremgangsmaate for behandling av fluoralumosilikatglass
NO934547D0 (no) Oral behandling av Helicobacter-in-feksjon
NO924461D0 (no) Dipyridamol for behandling av proliferaktive sykdommer
FI954047A0 (fi) Ihmisen interleukiini-10:n puhdistaminen
DE69401115D1 (de) Reinigung von Propylenoxid
NO940810D0 (no) Behandling av virusinfeksjoner
EP0559791A4 (en) Treatment of topical infections
DE69415387T2 (de) Reinigung von Propylenoxid
DE69227952D1 (de) Reinigung von Propylenoxid
FI932847A0 (fi) HIV-proteasinhibitorer som aer anvaendbara foer behandling av aids
DE69102980D1 (de) Reinigung von Siliziumtetrachlorid.
DE69301599D1 (de) Reinigung von Propylenoxid
LV10191A (lv) Farmaceitiski lidzekli hepatita B virusa izraisito infekciju un slimibu arstesanai
NO951995L (no) Kombinasjon av atovaquon med proguantil for behandling av protozoinfeksjoner
NO942756D0 (no) Behandling av glaucoma
NO940190D0 (no) Anvendelse av x-ketoglutarat
FI951655A (fi) H.pylori -infektioiden hoito
FI935202A (fi) Tenn/ceriumfoereningar foer processering av lignosulfonat
AU3530395A (en) Treatment of viral infections
NO965591D0 (no) Kombinasjonsbehandling av HIV-infeksjon
NO931399D0 (no) Anvendelse av naturstein
EP0655919A4 (en) TREATMENT OF VIRAL INFECTIONS IN MAN.
NO960551D0 (no) Antistoff basert behandling av HIV infeksjon
DK8492D0 (da) Behandling af psykoser